Novo raises full-year outlook on continued GLP-1 momentum
FROM THE WIRE · MANILATIMES.NET
4 November - Financial report for the period 1 January 2026 to 30 September 2026
Read at the source ↗MARKET IMPACTHIGH✦ News Impact agent estimateTone: expected bullishA raised full-year outlook from a large pharma group can move the healthcare sector and the Danish market.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Novo Nordisk raises its full-year outlook.
- 02Third-quarter adjusted operating profit rises 27% at constant exchange rates to DKK 31,720 million.
- 03The financial report covers the period from 1 January to 30 September 2026.